Bill & Melinda Gates Foundation gives Dare Bioscience a boost

FAN Editor

Shares of Daré Bioscience, Inc., surged 63% ahead of Wednesday’s opening bell after the biotech company reported a nearly $49 million grant from The Bill & Melinda Gates Foundation.

The stock remained up more than 20% as of Wednesday morning. Shares closed at $1.52 on Tuesday and opened at $2.26 on Wednesday.

CLICK HERE TO READ MORE ON FOX BUSINESS

The company received the grant in the first quarter of 2021 to further research for its DARE-LARC1 program, which Daré describes as a “long-acting reversible contraceptive,” according to its most recent SEC filing.

Daré will receive an initial $11.5 million this month, and additional payments will be made upon the DARE-LARC1 program’s achievements and reporting milestones, according to the agreement published on June 30.

GET FOX BUSINESS ON THE GO BY CLICKING HERE 

As part of the contract, Daré agreed to make the program and its related initiatives affordable for patients “most in need within developing countries, or in support of the U.S. educational system and public libraries.”

Free America Network Articles

Leave a Reply

Next Post

U.S. SEC to consider new ‘sustainable’ fund criteria, data disclosure rules

July 7, 2021 By Katanga Johnson WASHINGTON (Reuters) – U.S. Securities and Exchange Commission (SEC) Chair Gary Gensler said on Wednesday he has asked the regulator’s staff to consider rules that would require self-proclaimed “sustainable” fund managers to disclose the criteria and underlying data used to support the label. There […]